PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK Emergency Departments

This tender has closed.

See what's open in public administration and defence services, or get contracts like this in your inbox each morning — free.

About this contract

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will: - rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets; - monitor the emergence of a synthetic opioid market as seen in North America; - identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids. Additional information: Proposals should be emailed to jade.palmer@phe.gov.uk and include the following documentation / information: 1. supporting statement setting out and establishing suitability to undertake the project, including evidence of national/international work within the field of laboratory analysis of illicit drugs/clinical toxicology and programme management; 2. project outline with details of methodology including proposed strategy for laboratory analysis (offering the most cost-effective options most likely to ensure signals are picked up), timescales, and risks; 3. budget (including detailed breakdown of spend); 4. project team CVs. Word count (excluding project team CVs and budget) is a max of 4,000 words.

Key dates

Source

Who to contact

Tender documents